Activity Number:
|
230
|
Type:
|
Luncheons
|
Date/Time:
|
Tuesday, August 13, 2002 : 12:30 PM to 1:50 PM
|
Sponsor:
|
WNAR
|
Abstract - #302005 |
Title:
|
Software for Group Sequential Trials
|
Author(s):
|
Scott Emerson*+ and Cyrus Mehta*+
|
Affiliation(s):
|
University of Washington and Cytel Software Corporation
|
Address:
|
Box 357232, Seattle, Washington, 98195, 675 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA
|
Keywords:
|
|
Abstract:
|
Group sequential designs offer substantial benefits over traditional fixed-sample designs. This is especially important for Phase II and Phase III clinical trials, where ethical considerations such as patient safety and rapid approval of effective treatments are paramount. The FDA now recommends group sequential studies in certain cases. The discussion leaders are principal developers of the two leading software packages for group sequential design and monitoring, EaST and S+SeqTrial. Discussion will include current issues in the field, capability of existing packages, and future directions.
|
- The address information is for the authors that have a + after their name.
- Authors who are presenting talks have a * after their name.
Back to the full JSM 2002 program |